CELIXIR

Class [005]
Pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for cardiovascular, cardiopulmonary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory and gastrointestinal diseases; pharmaceutical preparations for the treatment of diseased skin, tissue, organs and body parts in the nature of treatment for genitourinary diseases, namely, urological diseases and disorders, infertility, sexually transmitted diseases, inflammatory pelvic diseases, vaginal infections and genital infestations; pharmaceutical preparations for the treatment of viral diseases, namely human immunodeficiency virus (HIV), human papilloma virus (HPV), respiratory syncytial virus (RSV), hepatitis, herpes genitalis, herpes labialis, herpes simplex virus, mumps, shingles, chicken pox, varicella-zoster virus, Epstein-Barr virus and cytomegalovirus; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of disorders of the endocrine system, namely diabetes, thyroid disorders, metabolic syndrome and osteoporosis; pharmaceutical preparations for the treatment of musculoskeletal diseases, disorders and injuries, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of dermatological diseases and disorders, namely dermatitis, skin pigmentation diseases, skin and skin structure infections namely bacterial skin infections, fungal skin infections, viral skin infections and parasitic skin infections, psoriasis, eczema and sexually transmitted diseases; pharmaceutical preparations for the treatment of hormonal related diseases and disorders, namely hypogonadism, testosterone/androgen disorders and estrogen disorders; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely mood disorders, anxiety disorders, cognitive disorders, schizophrenia, and psychoses; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely Parkinson's Disease, Alzheimer's Disease, Huntington's Disease, dementia, migraine, cerebral palsy, brain injury, spinal cord injury, seizure disorders, epilepsy, restless legs syndrome, pain, neuropathic pain, inflammatory-related pain, fibromyalgia, stroke, multiple sclerosis, insomnia; pharmaceutical preparations for the treatment of central nervous system diseases, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the treatment of immune system related diseases and disorders, namely immunosuppressants; pharmaceutical preparations for the treatment of immunologic diseases and disorders, namely autoimmune diseases and disorders, immunologic deficiency syndromes; pharmaceutical and veterinary pharmaceutical preparations for use in promoting cellular, tissue, and organ regeneration; pharmaceutical preparations for use in facilitating regeneration of damaged and diseased skin, tissue and organs; cellular medicines, namely, stem cells, tissue engineered cells and gene edited cells for medical and veterinary purposes; food for babies; material for stopping teeth, dental wax; preparations for destroying vermin; fungicides, herbicides;